Russell P. “Rip” Wilson
Senior Vice President, Business Development

Mr. Wilson is Senior Vice President, Business Development with responsibility for developing business alliances, license arrangements, and partnering opportunities with pharmaceutical companies and government agencies. Prior to joining Novavax in November 2011, Mr. Wilson was most recently the Chief Financial Officer at Supernus Pharmaceuticals. He was previously Senior Vice President, Chief Financial Officer and General Counsel of Iomai Corporation, which was acquired in 2008 by Intercell AG, during which time he successfully negotiated a $128 million government contract with the Office of Biomedical Research and Development Authority (BARDA) at the U.S. Department of Health and Human Services. Mr. Wilson was also the Acting General Counsel of North American Vaccine, Inc. until its acquisition by Baxter International in 2000. Mr. Wilson received his Bachelor of Arts degree in History from Princeton University, his Master in Business Administration and Juris Doctorate degrees from the University of Virginia.